Burning mouth treatments show promise, but evidence remains limited
A review found symptom improvement with several approaches, without enough consistent evidence to establish a preferred initial treatment.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review identified symptom-relief signals for topical clonazepam, alpha-lipoic acid and low-level laser therapy in people with burning mouth syndrome. However, substantial differences between studies prevented a pooled estimate. The abstract does not establish how much pain relief to expect or which option should be preferred as an initial treatment.
No treatment-specific effect sizes, follow-up periods or detailed bias results are provided. The authors describe the overall evidence as limited and call for larger, higher-quality trials before firm initial-treatment recommendations.
How treatments were assessed
Researchers grouped trials by intervention type, covering medicines, topical products, physical approaches and combinations. They assessed symptom relief and adverse effects, but differences in methods and clinical features meant results could only be summarized qualitatively.
What safety reporting adds
The abstract reports few mild adverse effects for the highlighted therapies, without detailed safety results. Its authors also say stronger trials are needed before deciding which treatments should be offered first.
The original publication
Efficacy of different therapeutic options for pain relief and treatment of burning mouth syndrome: a systematic review.
Rossetti A, Teixeira A, Milhazes N
Clin Oral Investig · 2025
- PubMed ID
- 41193828
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.